(Q74221086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Consistency of the efficacy of cetirizine and ebastine on skin reactivity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Frossard N

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Melac M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Benabdesselam O

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pauli G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

61-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Ebastine in chronic urticaria: A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Assessment of the wheal size and skin blood flow of the erythema induced by histamine and its modification with cetirizine and ebastine: a crossover, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Inhibitory Effects of Orally or Sublingually Administered Cetirizine on Histamine-induced Weals and Flares and Their Correlation with Cetirizine Plasma Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Quantitation of H1-receptor antagonists in skin and serum

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

The antiallergic effects of antihistamines (H1-receptor antagonists)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962941-9

7 January 2021

10.1016/S1081-1206(10)62941-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9475569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference